The pathogenesis of these anti-VE-cadherin autoantibodies might be of clinical interest, although future studies will need to confirm and fully establish the clinical relevance of anti-VE-cadherin autoantibodies in SLE (Figure 3A). Here, CDH5 is linked to systemic lupus erythematosus.